Research indexJournal article
Интегральная оценка факторов риска и прогностического значения нейромаркеров у больных с диабетической нефропатией
Yusupovich, Урманова, Хасанова
Профилактическая медицина и здоровье3 Aug 2026Open access
NobleIDark:/48914/w1/20261105/8ADE027ADOI10.47689/2181-3663-vol5-iss4-pp763-772
Интегральная оценка факторов риска и прогностического значения нейромаркеров у больных с диабетической нефропатией
Yusupovich, Урманова, Хасанова · Профилактическая медицина и здоровье · 2026
NobleIDark:/48914/w1/20261105/8ADE027ADOI10.47689/2181-3663-vol5-iss4-pp763-772
Abstract
Objective To perform an integrated assessment of risk factors and the prognostic value of neuromarkers in patients with diabetic nephropathy. Materials and Methods The clinical material comprised data from 150 patients with type 2 diabetes mellitus (T2DM) who were examined and treated at the Republican Specialized Scientific and Practical Medical Center of Endocrinology of the Ministry of Health of the Republic of Uzbekistan between 2000 and 2021 and were undergoing maintenance hemodialysis. The duration of chronic kidney disease (CKD) ranged from 1 to 15 years. According to the severity of chronic cerebral ischemia (CCI), the patients were divided into three groups: Group 1 included 50 (33.3%) patients with diabetic nephropathy, stage V CKD, and grade I CCI; Group 2 included 50 (33.3%) patients with diabetic nephropathy, stage V CKD, and grade II CCI; and Group 3 included 50 (33.3%) patients with diabetic nephropathy, stage V CKD, and grade III CCI. The control group consisted of 20 patients with stage I–II CKD. All patients underwent a comprehensive assessment that included general clinical, biochemical, and hormonal blood tests, instrumental examinations, and measurement of blood BDNF, S100B, and NSE levels. Results The developed scale for assessing the degree of association and etiological contribution of risk factors (RFs) for mortality made it possible to classify risk factors into three levels, providing a basis for developing a set of preventive measures aimed at preventing complications and reducing mortality. Conclusion Serum levels of BDNF, S100B, and NSE were found to have statistically significant prognostic value in patients with T2DM and stage V CKD, both before and during maintenance hemodialysis, for assessing the risk of cerebrovascular complications. An integrated assessment of risk factors for CCI in patients with T2DM and stage V CKD showed that the highest risk was observed in patients older than 60 years (28.17%), those with a disease duration of 16 years or more (35.58%), and those with harmful habits, particularly smoking (17.87%).